Royal Philips, a global health technology company has announced it signed a 10-year strategic partnership agreement with Rutherford Diagnostics. This collaboration will utilize Philips innovative radiology technology and Rutherford Diagnostics’ healthcare expertise to deliver and operate advanced personalized diagnostic services through a network of community diagnostic centers, driving the best possible healthcare outcomes for patients. Rutherford Diagnostics is a subsidiary of Proton Partners
Read More
Global Healthcare | Global Health Impact on Patients|News, Analysis, Insights - HIT Consultant
HIMSS Appoints Dr. Sebastian Krolop As Global Chief Operating & Strategy Officer
HIMSS, has announced the
appointment of Dr. Sebastian Krolop, MD, PhD, MSc, to the role of
chief operating & strategy officer (COSO). Under his leadership as COSO, Dr. Krolop will lead the alignment of HIMSS’s
operational goals with the organization’s strategic plan. In addition, he will
guide the direction of HIMSS
Analytics, HIMSS
Media and foster additional support services in international
markets.
Dr. Krolop Background/Experience
Dr. Krolop comes to the organization
Read More
FDA Approves Blockchain/IoT Pilot to Track Specialty Prescription Drugs Across 3 States
The U.S. Food and Drug Administration (FDA) has approved a multi-regional pilot studying the use of blockchain-enabled data technology to track and verify specialty prescription drugs, to ensure safety, enhance value and improve health outcomes.Blockchain Pilot Consortium & Implementation TimelineThe pilot consortium is comprised of Rymedi,Temptime/Zebra, Indiana University Health, WakeMed Health & Hospitals, Good Shepherd Pharmacy and its RemediChain project, as well as the Center for
Read More
Healthcare BPO: Assessing Your Outsourcing Services Maturity
In the healthcare market, there is increasing demand for outsourcing services that can bring strategic insights, optimization, and efficiencies to critical operations, particularly among health plans.These partnerships speak to the dramatic shifts in how health plans are sold and purchased today, but also to the maturity of the healthcare business process outsourcing (BPO) industry itself.Years ago, BPO was more tactical than strategic—lifting and shifting units or processes to a far-flung
Read More
PathAI Lands $60M to Accelerate AI-Powered Pathology Platform
PathAI, a Boston, MA-based provider of AI-powered pathology platform has raised $60M in Series B funding led by General Atlantic with strong participation from General Catalyst and other existing investors. General Atlantic Managing Director Dr. Michelle Dipp will be joining PathAI’s board of directors.Advanced Learning Towards Faster More Accurate Diagnosis of DiseaseCo-founded by Chief Executive Officer Dr. Andy Beck in 2016 with the mission to offer faster, safer and more powerful solutions
Read More
Where’s the Evidence? Barriers to Analyzing Digital Health’s Impact
The digital health industry continues to grow at an unprecedented rate. In 2018, venture funding for digital health companies approached a record $8.1B in funding, according to Rock Health. These companies are striving to address important healthcare issues by developing products and service offerings in various categories like genome sequencing, analytics, telemedicine, mobile apps, and population health management tools—all with the promise of increased insights and patient engagement, and
Read More
Livongo Adds HIPAA-Compliant Amazon Alexa Healthcare Skill for Diabetes
Livongo, the leading Applied Health Signals company, today announced the Livongo for Diabetes program will now leverage Amazon Alexa's voice service to offer its Members the ability to ask any of their Alexa-enabled devices to provide their blood glucose readings and health tips via the new Livongo skill. The integration marks Livongo as the first consumer digital health company to collaborate with Amazon Alexa on a new HIPAA-compliant healthcare skill, which builds on Livongo's efforts to make
Read More
TriNetX Acquires European Clinical Data Network InSite
TriNetX, a global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE) has acquired Belgium-based Custodix NV and its InSite network. InSite network is a European-based provider of services for clinical trial design, patient feasibility, and enabling workflow for patient recruitment. Financial details of the acquisition were not disclosed.
InSite Clinical Data Network Background
The InSite platform is an
Read More
Ada to Become the First AI-based Medical App to be Offered in Swahili
Ada will become the first health guidance app to feature Swahili language integration, making its health assessment technology available to more than 100 million people in Sub-Saharan Africa. Ada, an AI-powered health platform that helps individuals understand their health and navigate to appropriate care, announced the launch of its Global Health Initiative (GHI) through partnerships with the Bill and Melinda Gates Foundation and Foundation Botnar. GHI is a series of major projects focused on
Read More
DreaMed Diabetes Granted FDA Approval for Personalized Diabetes Decision Support Solution
DreaMed Diabetes, an Israeli-based developer of personalized diabetes management solutions, today announced that the U.S Food and Drug Administration (FDA) has granted a De Novo request for DreaMed Advisor Pro, an artificial intelligence (AI)-based diabetes treatment decision support software. Advisor Pro is indicated to assist healthcare providers in the management of people with type 1 diabetes who use insulin pumps and continuous glucose monitoring (CGM).The announcement marks the second
Read More
